Analystreport

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $12.00 price targe

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com